Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Preferred Shares: 2017-2019

Historic Preferred Shares for Aytu Biopharma (AYTU) over the last 1 years, with Dec 2019 value amounting to $1,022.

  • Aytu Biopharma's Preferred Shares rose 125.61% to $1,022 in Q4 2019 from the same period last year, while for Dec 2019 it was $1,022, marking a year-over-year increase of 125.61%. This contributed to the annual value of $359 for FY2019, which is N/A change from last year.
  • According to the latest figures from Q4 2019, Aytu Biopharma's Preferred Shares is $1,022, which was up 224.44% from $315 recorded in Q3 2019.
  • Aytu Biopharma's 5-year Preferred Shares high stood at $1,022 for Q4 2019, and its period low was $1 during Q3 2017.
  • For the 3-year period, Aytu Biopharma's Preferred Shares averaged around $340.71, with its median value being $315 (2019).
  • Data for Aytu Biopharma's Preferred Shares shows a peak YoY spiked of 45,200.00% (in 2018) over the last 5 years.
  • Over the past 3 years, Aytu Biopharma's Preferred Shares (Quarterly) stood at $1 in 2017, then surged by 45,200.00% to $453 in 2018, then spiked by 125.61% to $1,022 in 2019.
  • Its Preferred Shares stands at $1,022 for Q4 2019, versus $315 for Q3 2019 and $359 for Q2 2019.